Skip to main content
. 2016 Sep 23;49(3):616–626. doi: 10.4143/crt.2016.178

Table 1.

CR and ASR per 100,000a) for lung cancer and APC by sex and histological subtypes, the Korea Central Cancer Registry, 1999-2012

Histological group Rate Year
 APC 95% CI p-value
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Men
 Overall Cases 9,722 9,788 10,473 10,956 11,187 11,961 12,497 12,682 13,182 13,593 14,240 14,914 15,319 15,350
CR 41.1 41.0 43.6 45.4 46.2 49.2 51.2 51.7 53.5 54.9 57.2 59.7 61.1 60.9 3.4 3.1 to 3.6 < 0.01
ASRa) 51.8 50.3 51.5 51.6 50.4 51.3 51.6 49.9 49.4 48.3 48.2 48.1 47.2 44.9 −0.9 −1.2 to −0.6 < 0.01
 Carcinoma Cases 6,967 6,947 7,916 8,262 8,735 9,373 9,861 10,361 10,907 11,354 12,148 12,741 13,173 13,365
CR 29.4 29.1 32.9 34.2 36.0 38.5 40.4 42.3 44.3 45.9 48.8 51.0 52.5 53.1 5.0 4.6 to 5.4 < 0.01
ASRa) 36.0 34.6 37.8 37.8 38.3 39.2 39.6 39.9 40.0 39.6 40.5 40.6 40.2 38.8 0.9 0.5 to 1.3 < 0.01
 Squamous cell carcinoma Cases 3,394 3,256 3,572 3,746 3,724 4,000 4,034 4,172 4,312 4,097 4,575 4,627 4,707 4,737
CR 14.3 13.6 14.9 15.5 15.4 16.4 16.5 17.0 17.5 16.5 18.4 18.5 18.8 18.8 2.4 2.0 to 2.9 < 0.01
ASRa) 17.7 16.3 17.2 17.3 16.4 16.9 16.4 16.2 16.0 14.3 15.4 14.8 14.3 13.7 −1.7 −2.2 to −1.2 < 0.01
 Adenocarcinoma Cases 1,731 1,838 2,205 2,177 2,404 2,561 2,859 3,041 3,232 3,780 4,024 4,414 4,900 5,045
CR 7.3 7.7 9.2 9.0 9.9 10.5 11.7 12.4 13.1 15.3 16.2 17.7 19.5 20.0 8.3 7.8 to 8.8 < 0.01
ASRa) 8.8 9.0 10.4 9.8 10.3 10.5 11.3 11.5 11.7 13.1 13.3 14.0 14.9 14.7 4.1 3.6 to 4.6 < 0.01
 Small cell carcinoma Cases 1,260 1,238 1,355 1,408 1,460 1,530 1,474 1,557 1,721 1,733 1,839 1,969 1,971 2,045
CR 5.3 5.2 5.6 5.8 6.0 6.3 6.0 6.4 7.0 7.0 7.4 7.9 7.9 8.1 3.5 3.1 to 4.0 < 0.01
ASRa) 6.4 6.1 6.4 6.5 6.4 6.4 5.9 6.0 6.3 6.1 6.1 6.2 6.0 5.9 −0.5 −0.9 to −0.1 0.01
 Large cell carcinomab) Cases 483 490 643 572 325 267 312 340 269 275 264 281 263 233
CR 2.0 2.1 2.7 2.4 1.3 1.1 1.3 1.4 1.1 1.1 1.1 1.1 1.0 0.9 −6.8 −9.3 to −4.2 < 0.01
ASRa) 2.5 2.4 3.1 2.6 1.4 1.1 1.3 1.3 1.0 1.0 0.9 0.9 0.8 0.7 −10.4 −12.8 to −7.9 < 0.01
 Other specified carcinomas Cases 99 125 141 359 822 1,015 1,182 1,251 1,373 1,469 1,446 1,450 1,332 1,305
CR 0.4 0.5 0.6 1.5 3.4 4.2 4.8 5.1 5.6 5.9 5.8 5.8 5.3 5.2 22.4 13.0 to 32.7 < 0.01
ASRa) 0.5 0.6 0.7 1.6 3.6 4.2 4.7 4.8 5.0 5.1 4.8 4.6 4.1 3.8 17.9 8.7 to 28.0 < 0.01
 Sarcoma Cases 17 16 28 14 25 16 21 27 30 24 38 21 28 30
CR 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 4.0 0.5 to 7.7 0.03
ASRa) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 −2.3 to 5.0 0.46
 Other specified cancer (including pulmonary blastoma) Cases 9 10 8 9 10 10 10 16 11 11 9 6 11 10
CR 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 −0.2 −3.4 to 3.0 0.88
ASRa) 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 −3.9 −7.1 to −0.7 0.02
 Unspecified cancer Cases 2,729 2,815 2,521 2,671 2,417 2,562 2,605 2,278 2,234 2,204 2,045 2,146 2,107 1,945
CR 11.5 11.8 10.5 11.1 10.0 10.5 10.7 9.3 9.1 8.9 8.2 8.6 8.4 7.7 −3.0 −3.6 to −2.4 < 0.01
ASRa) 15.7 15.6 13.5 13.7 12.0 12.0 11.8 9.8 9.2 8.6 7.5 7.4 6.9 6.0 −7.2 −7.8 to −6.5 < 0.01
Women
 Overall Cases 3,458 3,588 3,654 3,913 3,987 4,379 4,728 5,035 5,234 5,523 5,791 6,223 6,657 6,738
CR 14.7 15.2 15.3 16.3 16.6 18.1 19.5 20.7 21.4 22.4 23.4 25 26.6 26.8 5.2 4.8 to 5.5 < 0.01
ASRa) 12.9 12.9 12.7 13 12.8 13.5 14 14.5 14.4 14.5 14.6 15.2 15.6 15.3 1.7 1.4 to 2.0 < 0.01
 Carcinoma Cases 2,005 2,070 2,282 2,489 2,654 2,943 3,223 3,674 3,937 4,266 4,505 4,851 5,292 5,524
CR 8.5 8.7 9.6 10.4 11.0 12.2 13.3 15.1 16.1 17.3 18.2 19.5 21.1 22.0 8.1 7.7 to 8.6 < 0.01
ASRa) 7.8 7.8 8.3 8.7 8.9 9.6 10.1 11.1 11.4 11.9 12.1 12.6 13.2 13.2 4.7 4.3 to 5.1 < 0.01
 Squamous cell carcinoma Cases 364 357 367 386 375 427 427 503 443 439 440 485 523 473
CR 1.5 1.5 1.5 1.6 1.6 1.8 1.8 2.1 1.8 1.8 1.8 1.9 2.1 1.9 2.2 1.3 to 3.1 < 0.01
ASRa) 1.4 1.3 1.3 1.3 1.2 1.3 1.3 1.4 1.2 1.1 1.1 1.1 1.2 1.0 −1.7 −2.6 to −0.8 < 0.01
 Adenocarcinoma Cases 1,195 1,267 1,394 1,479 1,626 1,834 2,029 2,314 2,601 2,864 3,178 3,422 3,839 4,161
CR 5.1 5.4 5.8 6.2 6.8 7.6 8.4 9.5 10.6 11.6 12.8 13.7 15.3 16.5 10.0 9.6 to 10.5 < 0.01
ASRa) 4.7 4.8 5.2 5.2 5.5 6.1 6.5 7.2 7.7 8.2 8.7 9.1 9.8 10.2 6.6 6.2 to 7.1 < 0.01
 Small cell carcinoma Cases 266 240 276 294 321 273 287 327 319 366 308 392 384 409
CR 1.1 1.0 1.2 1.2 1.3 1.1 1.2 1.3 1.3 1.5 1.2 1.6 1.5 1.6 2.9 1.8 to 4.1 < 0.01
ASRa) 1.0 0.9 1.0 1.0 1.0 0.8 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 −1.1 −2.1 to 0.0 0.06
 Large cell carcinomab) Cases 132 148 179 184 88 77 86 95 82 71 78 88 81 77
CR 0.6 0.6 0.8 0.8 0.4 0.3 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 −6.2 −9.2 to −3.1 < 0.01
ASRa) 0.5 0.5 0.6 0.6 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 −9.9 −12.6 to −7.0 < 0.01
 Other specified carcinomas Cases 48 58 66 146 244 332 394 435 492 526 501 464 465 404
CR 0.2 0.2 0.3 0.6 1.0 1.4 1.6 1.8 2.0 2.1 2.0 1.9 1.9 1.6 19.1 11.3 to 27.5 < 0.01
ASRa) 0.2 0.2 0.3 0.5 0.8 1.1 1.3 1.3 1.4 1.4 1.4 1.2 1.2 1.0 14.9 7.4 to 22.9 < 0.01
 Sarcoma Cases 9 4 7 8 12 12 18 16 15 7 5 24 16 10
CR 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 4.5 −2.6 to 12.1 0.20
ASRa) 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.8 −4.8 to 8.8 0.58
 Other specified cancer (include pulmonary blastoma) Cases 4 4 5 5 2 2 1 11 1 7 3 7 10 5
CR 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 −7.2 to 15.9 0.48
ASRa) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 −8.1 to 11.9 0.76
 Unspecified cancer Cases 1,440 1,510 1,360 1,411 1,319 1,422 1,486 1,334 1,281 1,243 1,278 1,341 1,339 1,199
CR 6.1 6.4 5.7 5.9 5.5 5.9 6.1 5.5 5.2 5.0 5.2 5.4 5.3 4.8 −1.6 −2.3 to −1.0 < 0.01
ASRa) 5.1 5.1 4.3 4.3 3.8 3.8 3.8 3.3 2.9 2.6 2.5 2.5 2.4 2.0 −6.8 −7.5 to −6.1 < 0.01

CRs and ASRs were expressed per 100,000 people. CR, crude rate; ASR, age-standardized rate; APC, annual percent change; CI, confidence interval.

a)

The Korean population in 2000 was used as standard population,

b)

Large cell carcinoma includes giant cell, clear cell, and large cell undifferentiated carcinoma.